Raymond James Financial Inc Astrazeneca PLC Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Raymond James Financial Inc holds 2,295,589 shares of AZN stock, worth $165 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,295,589
Previous 2,411,756
4.82%
Holding current value
$165 Million
Previous $158 Million
6.78%
% of portfolio
0.07%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,429Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.11 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.29 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.25 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...